Discontinued — last reported Q1 '16
Business Segments · Net Revenue
Genomic And Esoteric Testing — Net Revenue
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2016
Rolls up toTotal Revenue
How to read this metric
An increase indicates successful expansion into high-value diagnostic markets and strong demand for precision medicine, while a decrease may signal increased competition or pricing pressure in specialized testing segments.
Detailed definition
This metric represents the net revenue generated from specialized laboratory services, including advanced genomic sequen...
Peer comparison
Peers in the diagnostic and life sciences sector often report this under 'Specialty Testing' or 'Molecular Diagnostics' revenue, with growth rates typically correlated to R&D investment and clinical adoption of new biomarkers.
Metric ID:
lh_segment_genomic_and_esoteric_testing_sales_revenue_netSimilar Metrics at Other Companies
Frequently Asked Questions
- What does genomic and esoteric testing — net revenue mean?
- Net revenue earned from high-complexity genomic and specialized diagnostic laboratory testing services.